Ting Wei Selected Research

Non-alcoholic Fatty Liver Disease

9/2014	Flavonoid ingredients of Ginkgo biloba leaf extract regulate lipid metabolism through Sp1-mediated carnitine palmitoyltranferase 1A up-regulation.
10/2012	Inhibitory effect of Ginkgo biloba extract on fatty liver: regulation of carnitine palmitoyltransferase 1a and fatty acid metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ting Wei Research Topics

Disease

58	Neoplasms (Cancer) 03/2024 - 05/2008
11	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 11/2015
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2010
8	Infections 01/2020 - 03/2003
7	Melanoma (Melanoma, Malignant) 01/2024 - 01/2021
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2019
5	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2019
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2012
5	Hemangioma (Angioma) 11/2021 - 04/2005
4	Adenocarcinoma of Lung 03/2024 - 01/2020
4	Inflammation (Inflammations) 01/2023 - 04/2013
3	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2023 - 01/2014
3	Neoplasm Metastasis (Metastasis) 11/2023 - 06/2009
3	COVID-19 01/2023 - 08/2021
3	Hypersensitivity (Allergy) 11/2021 - 05/2005
3	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2021 - 04/2013
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2020
3	Carcinogenesis 03/2020 - 11/2016
2	Idiopathic Pulmonary Fibrosis 01/2023 - 12/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2021
2	Body Weight (Weight, Body) 01/2023 - 01/2023
2	Obesity 01/2023 - 01/2023
2	Bites and Stings (Sting) 01/2023 - 11/2021
2	Fibrosis (Cirrhosis) 01/2022 - 02/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2021
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2021 - 03/2021
2	Arteriovenous Malformations (Arteriovenous Malformation) 12/2019 - 04/2016
2	Hemolysis 05/2019 - 05/2018
2	Nasopharyngeal Carcinoma 08/2017 - 10/2011
2	Reperfusion Injury 02/2015 - 01/2014
2	Glaucoma 02/2015 - 01/2014
2	Non-alcoholic Fatty Liver Disease 09/2014 - 10/2012
1	Cerebral Hemorrhage 02/2024
1	Brain Injuries (Brain Injury) 02/2024
1	Brain Edema (Cerebral Edema) 02/2024

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2004
12	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
7	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2020
5	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2020
5	AntigensIBA 01/2024 - 03/2004
5	EnzymesIBA 01/2023 - 04/2008
5	LipidsIBA 01/2023 - 04/2013
4	Biocompatible Materials (Biomaterials)IBA 11/2023 - 07/2018
4	MicroRNAs (MicroRNA)IBA 02/2021 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2019
4	PolymersIBA 05/2019 - 01/2016
4	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 08/2017 - 06/2010
3	Peptides (Polypeptides)IBA 11/2023 - 05/2018
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023 - 01/2021
3	CateninsIBA 01/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2023 - 03/2017
3	PlatinumIBA 01/2022 - 01/2019
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 10/2012
3	LipopolysaccharidesIBA 02/2021 - 04/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2019
3	Histones (Histone)IBA 01/2021 - 01/2021
3	Propranolol (Inderal)FDA LinkGeneric 01/2021 - 01/2017
2	Small Cytoplasmic RNAIBA 03/2024 - 01/2022
2	AntibodiesIBA 01/2024 - 03/2004
2	ChitosanIBA 01/2024 - 11/2023
2	FluorocarbonsIBA 01/2024 - 11/2023
2	NanovaccinesIBA 01/2024 - 01/2023
2	Cancer VaccinesIBA 01/2024 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 03/2023
2	OvalbuminIBA 11/2023 - 01/2023
2	HydrogelsIBA 11/2023 - 01/2023
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2023 - 12/2022
2	TOR Serine-Threonine KinasesIBA 01/2023 - 12/2022
2	Amino Acids FDA Link 01/2023 - 01/2021
2	RNA Polymerase I (Polymerase I, RNA)IBA 01/2023 - 04/2018
2	TeaIBA 01/2023 - 01/2023
2	InterferonsIBA 01/2023 - 01/2021
2	AntioxidantsIBA 01/2023 - 01/2023
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2022 - 12/2018
2	Therapeutic UsesIBA 12/2022 - 04/2017
2	CollagenIBA 12/2022 - 12/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2021
2	Long Noncoding RNAIBA 02/2021 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2021 - 05/2015
2	AndrogensIBA 01/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 12/2019 - 06/2010
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017 - 11/2016
2	Liposomes (Liposome)IBA 11/2016 - 05/2015
2	Retinaldehyde (Retinal)IBA 02/2015 - 01/2014
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2013 - 06/2012
2	N-AcetylglucosaminyltransferasesIBA 08/2012 - 10/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2008 - 04/2005
2	Recombinant ProteinsIBA 04/2008 - 03/2004
1	aflutinibIBA 03/2024
1	EdaravoneIBA 02/2024
1	Viral VaccinesIBA 01/2024
1	LigandsIBA 01/2024

Therapy/Procedure

26	Therapeutics 03/2024 - 04/2005
15	Immunotherapy 03/2024 - 01/2019
10	Drug Therapy (Chemotherapy) 03/2024 - 06/2009
3	Radiotherapy 11/2023 - 08/2014
3	Castration 01/2022 - 07/2019
2	Intravenous Injections 01/2024 - 01/2023
2	Intravitreal Injections 01/2023 - 11/2019
1	Radiofrequency Ablation 01/2024